H
Hongguang Zheng
Publications - 7
Citations - 140
Hongguang Zheng is an academic researcher. The author has contributed to research in topics: Renal function & Internal medicine. The author has an hindex of 2, co-authored 3 publications receiving 115 citations.
Papers
More filters
Journal ArticleDOI
A multicenter application and evaluation of the oxford classification of IgA nephropathy in adult chinese patients.
Caihong Zeng,Weibo Le,Zhaohui Ni,Minfang Zhang,Li-Ning Miao,Ping Luo,Rong Wang,Zhimei Lv,Jianghua Chen,Jiong Tian,Nan Chen,Xiaoxia Pan,Ping Fu,Zhang-Xue Hu,Lining Wang,Qiuling Fan,Hongguang Zheng,Dewei Zhang,Yaping Wang,Yanhong Huo,Hongli Lin,Shuni Chen,Shiren Sun,Yanxia Wang,Zhangsuo Liu,Dong Liu,Lu Ma,Tao Pan,Ai-ping Zhang,Xiaoyu Jiang,Changying Xing,Bing Sun,Qiao-ling Zhou,Wenbing Tang,Fuyou Liu,Yinghong Liu,Shaoshan Liang,Feng Xu,Qian Huang,Hongbing Shen,Jianming Wang,Yu Shyr,Sharon Phillips,Stéphan Troyanov,Agnes B. Fogo,Zhihong Liu +45 more
TL;DR: The associations of mesangial hypercellularity and tubular atrophy/interstitial fibrosis with kidney disease outcomes were confirmed, and the inclusion criteria and statistical analysis were similar to the Oxford study.
Journal ArticleDOI
Safety and effectiveness evaluation of a domestic peritoneal dialysis fluid packed in non-PVC bags: study protocol for a randomized controlled trial
Jianhui Zhou,Xueying Cao,Hongli Lin,Zhaohui Ni,Yani He,Menghua Chen,Hongguang Zheng,Xiangmei Chen +7 more
TL;DR: This study is the first to evaluate the long-term safety and effectiveness of a non-PVC packed peritoneal dialysis fluid and the effects of plasticizer on patient long- term survival.
Journal ArticleDOI
Efficacy and safety of Abelmoschus manihot in treating chronic kidney diseases: A multicentre, open-label and single-arm clinical trial.
Xuefeng Sun,Ping-zhu Li,Hongli Lin,Zhaohui Ni,Yongli Zhan,Guangyan Cai,Chao Liu,Qinkai Chen,Wenge Wang,Xiaoqin Wang,Pei-qing Zhang,Peng Li,Meng Liang,Hongguang Zheng,Niansong Wang,Lining Miao,Ruixia Jin,Zhiyong Guo,Yong Wang,Xiangmei Chen +19 more
TL;DR: In this paper , the authors evaluated the safety of AM combination application, and further verified the efficacy of AM in treating various types of chronic kidney disease (CKD) in a multicentre, prospective, open-label, single-arm trial.
Journal ArticleDOI
Randomized Phase 2 Trial of Telitacicept in Patients With IgA Nephropathy With Persistent Proteinuria
Jicheng Lv,Laijun Liu,Chuanming Hao,Gui-sen Li,Ping Fu,Guangqun Xing,Hongguang Zheng,Nan Chen,Caili Wang,Ping Lu,De-Qiong Xie,Lei Zuo,Rongshan Li,Yonghui Mao,Shaoshao Dong,Peng Zhang,Huixiao Zheng,Yue Wang,Wei Qin,Wenxiang Wang,Lin Li,Wenjuan Jiao,Jianmin Fang,Long Zhang +23 more
TL;DR: In this article , the authors evaluated the efficacy and safety of telitacicept in patients with immunoglobulin A nephropathy (IgAN) using a randomized placebo-controlled trial, where participants with an estimated glomerular filtration rate (eGFR) > 35 ml/min per 1.73 m2 and proteinuria ≥ 0.75 g/d despite optimal supportive therapy, were randomized 1:1:1 to receive subcutaneous telitcicept 160 mg, telitcapt 240 mg, or placebo weekly for 24 weeks.
Journal ArticleDOI
Evaluation of the Barrier Effect of Polylactic Acid-Modified Membrane on Odours at the Excavated Soil Interface of a Pesticide-Contaminated Site
TL;DR: Wang et al. as discussed by the authors investigated the barrier effect of the PLA modified membrane on odours at the excavated soil interface of a pesticide-contaminated site in Guangdong Province, China.